4.7 Letter

Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases

Journal

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 19, Issue 2, Pages 394-+

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2020.10.010

Keywords

-

Funding

  1. Helmsley Charitable Trust [2003-04445]
  2. Clinical and Translational Science Awards [UL1TR002489, T32DK007634, K23KD111995-01A1]
  3. Pfizer
  4. Takeda
  5. Janssen
  6. AbbVie
  7. Lilly
  8. Genentech
  9. Boehringer Ingelheim
  10. Bristol Myers Squibb
  11. Celtrion
  12. Arenapharm

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available